Latest Insider Transactions at Nex Immune, Inc. (NEXI)
This section provides a real-time view of insider transactions for Nex Immune, Inc. (NEXI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NexImmune, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NexImmune, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 11
2024
|
Kristi Jones President and CEO |
BUY
Open market or private purchase
|
Direct |
1
+50.0%
|
$0
$0.01 P/Share
|
Nov 22
2023
|
Alan S. Roemer Director |
SELL
Open market or private sale
|
Direct |
3,992
-100.0%
|
$3,992
$1.94 P/Share
|
Nov 21
2023
|
Alan S. Roemer Director |
SELL
Open market or private sale
|
Direct |
3,833
-48.98%
|
$7,666
$2.16 P/Share
|
Mar 30
2023
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
400,000
+15.28%
|
$0
$0.41 P/Share
|
Nov 26
2022
|
Kristi Jones President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
296,700
+44.52%
|
-
|
Nov 22
2022
|
Mathias Oelke Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct |
126,100
+48.48%
|
-
|
Nov 22
2022
|
John Trainer Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,200
+40.11%
|
-
|
Nov 17
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
75,000
+3.96%
|
$0
$0.48 P/Share
|
Nov 16
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
125,000
+6.69%
|
$0
$0.48 P/Share
|
Jun 07
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
26,876
+2.37%
|
$53,752
$2.28 P/Share
|
Jun 06
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
25,000
+2.27%
|
$50,000
$2.14 P/Share
|
Jun 03
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
15,000
+1.4%
|
$30,000
$2.22 P/Share
|
Jun 02
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
20,720
+1.26%
|
$41,440
$2.22 P/Share
|
Jun 02
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
47,900
+4.41%
|
$95,800
$2.23 P/Share
|
Jun 01
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
40,000
+2.44%
|
$80,000
$2.35 P/Share
|
Jun 01
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
40,200
+3.9%
|
$80,400
$2.38 P/Share
|
May 31
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
39,280
+2.46%
|
$78,560
$2.19 P/Share
|
May 31
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
45,024
+4.52%
|
$90,048
$2.11 P/Share
|
Mar 29
2022
|
Kristi Jones President and CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+12.04%
|
$30,000
$3.74 P/Share
|
Mar 28
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
18,983
+2.05%
|
$56,949
$3.76 P/Share
|
Mar 25
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
131,622
+12.93%
|
$526,488
$4.14 P/Share
|
Mar 24
2022
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
39,995
+5.03%
|
$119,985
$3.35 P/Share
|
Mar 23
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.65%
|
$20,000
$2.67 P/Share
|
Mar 22
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
30,000
+1.95%
|
$60,000
$2.41 P/Share
|
Mar 21
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
30,000
+1.99%
|
$60,000
$2.14 P/Share
|
Mar 18
2022
|
Sol J Barer |
BUY
Open market or private purchase
|
Direct |
30,000
+2.03%
|
$60,000
$2.11 P/Share
|
Dec 21
2021
|
Sol J Barer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+3.41%
|
$250,000
$5.17 P/Share
|
Dec 21
2021
|
Alan S. Roemer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67,657
+11.22%
|
$202,971
$3.1 P/Share
|
Jul 08
2021
|
John Trainer Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+5.26%
|
$17,160
$5.17 P/Share
|
Jun 08
2021
|
John Trainer Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+5.56%
|
$17,160
$5.17 P/Share
|
May 08
2021
|
John Trainer Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+5.88%
|
$17,160
$5.17 P/Share
|
Apr 08
2021
|
John Trainer Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+6.25%
|
$17,160
$5.17 P/Share
|
Mar 10
2021
|
John Trainer Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,432
+6.67%
|
$17,160
$5.17 P/Share
|
Feb 17
2021
|
Sol J Barer |
BUY
Conversion of derivative security
|
Indirect |
1,695,583
+25.46%
|
-
|
Feb 17
2021
|
Sol J Barer |
BUY
Open market or private purchase
|
Indirect |
60,000
+3.75%
|
$1,020,000
$17.0 P/Share
|
Feb 17
2021
|
Sol J Barer |
BUY
Conversion of derivative security
|
Direct |
800,182
+36.91%
|
-
|
Feb 17
2021
|
Timothy Bertram |
BUY
Conversion of derivative security
|
Direct |
71,749
+26.12%
|
-
|
Feb 17
2021
|
Scott Carmer President and CEO |
BUY
Conversion of derivative security
|
Direct |
7,058
+50.0%
|
-
|
Feb 17
2021
|
Paul D'Angio |
BUY
Conversion of derivative security
|
Direct |
27,847
+25.87%
|
-
|
Feb 17
2021
|
Grant Verstandig |
BUY
Open market or private purchase
|
Direct |
175,000
+19.67%
|
$2,975,000
$17.0 P/Share
|
Feb 17
2021
|
Grant Verstandig |
BUY
Conversion of derivative security
|
Direct |
539,895
+50.0%
|
-
|
Feb 17
2021
|
Alan S. Roemer Director |
BUY
Conversion of derivative security
|
Direct |
127,984
+20.46%
|
-
|
Feb 17
2021
|
Jerome B Zeldis Executive VP of Research & Dev |
BUY
Open market or private purchase
|
Direct |
5,882
+50.0%
|
$99,994
$17.0 P/Share
|
Feb 17
2021
|
Kristi Jones President and CEO |
BUY
Open market or private purchase
|
Direct |
911
+1.42%
|
$15,487
$17.0 P/Share
|
Feb 17
2021
|
Kristi Jones President and CEO |
BUY
Conversion of derivative security
|
Direct |
14,738
+19.16%
|
-
|